Modulus is engineering next-generation immune cell therapies, starting with Natural Killer cells rationally designed for the treatment of solid tumors.
Location: United States, Washington, Seattle
Total raised: $3.5M
Investors 2
| Date | Name | Website |
| - | KdT Ventur... | kdtvc.com |
| 16.07.2021 | Madrona Ve... | madrona.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.07.2021 | Seed | $3.5M | - |
Mentions in press and media 3
| Date | Title | Description |
| 20.03.2026 | Andrew Kossack: The Midwest can be next arsenal of American defense | - |
| 15.07.2021 | Modulus Therapeutics Secures $3.5 Million Seed Funding for AI-powered Cell Therapy Design Platform | Seattle-based AI hot startup, Modulus Therapeutics has announced it completed an oversubscribed $3.5 million Seed round. The new funding will be used to expand the development of Modulus’ Convergent Design™ platform. This AI-powered platfor... |
| 15.07.2021 | Modulus, a cell therapy biotech incubated at the Allen Institute for AI, raises $3.5M | Human natural killer cell. (National Institute of Allergy and Infectious Diseases Image) Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2), announced $3.5 million... |